S100A8 and prostate cancer: Increasing experimental and clinical evidence suggests that changes in the expression and function of S100 proteins play a crucial role during cancer development: S100A8 and S100A9 up-regulation in serum was described in breast, lung, gastric, colorectal, pancreatic, and prostate cancer, as well as in BCs [6, 13].